Company Filing History:
Years Active: 2025
Title: Galla Pericot Mohr: Innovator in Pharmaceutical Treatments
Introduction
Galla Pericot Mohr is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of phenylketonuria. His innovative approach has led to the development of a unique compound that holds promise for patients suffering from this metabolic disorder.
Latest Patents
Galla Pericot Mohr holds 1 patent for his invention titled "Triamterene or nolatrexed for use in the treatment of phenylketonuria." This patent relates to a compound selected from a group that includes nolatrexed, triamterene, sultopride, and hydrastinine, or a pharmaceutically acceptable salt thereof. The invention focuses on the use of these compounds, particularly triamterene and nolatrexed, in the treatment and prevention of phenylketonuria. It also encompasses the manufacturing of medicaments using these compounds and their combinations.
Career Highlights
Throughout his career, Galla Pericot Mohr has worked with various companies, including Som Innovation Biotech, S.A. and Som Innovation Biotech, S.L. His work in these organizations has allowed him to further his research and development efforts in the pharmaceutical industry.
Collaborations
Galla has collaborated with notable colleagues such as Raúl Insa Boronat and Núria Reig Bolaño. These partnerships have contributed to the advancement of his research and the successful development of his patent.
Conclusion
Galla Pericot Mohr is a distinguished inventor whose work in pharmaceuticals has the potential to impact the treatment of phenylketonuria significantly. His innovative spirit and dedication to research continue to inspire advancements in medical science.